SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-013049
Filing Date
2023-04-20
Accepted
2023-04-20 13:23:09
Documents
13
Period of Report
2023-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55224
2 ex10-1.htm EX-10.1 31638
  Complete submission text file 0001493152-23-013049.txt   265102

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mrzm-20230414.xsd EX-101.SCH 3227
4 XBRL LABEL FILE mrzm-20230414_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE mrzm-20230414_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3390
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 23832349
SIC: 2834 Pharmaceutical Preparations